» Articles » PMID: 32904864

Kaposi's Sarcoma-associated Herpesvirus Related Malignancy in India, a Rare but Emerging Member to Be Considered

Overview
Journal Virusdisease
Publisher Springer
Specialty Microbiology
Date 2020 Sep 9
PMID 32904864
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is associated with viral malignancy, related to HIV-AIDS. With a wide geographical discrimination in its occurrence, Asian countries shows low to moderate prevalence with higher occurrence in some particular areas. India is one of the largest countries in Asia, having various geographical and cultural variations where KSHV has been considered as an unthinkable entity to cause any of its associated disease. India has been reported as a low prevalent zone for KSHV malignancy till date. Also there are no reports so far, describing the occurrence pattern of this malignancy. So this review approaches towards figuring out the tendency of prevalence pattern of this malignancy and associated risk factors found to be present in Indian population. From this study it is revealed that, KSHV related malignancy is a relatively newly reported and emerging disease in India and may exist in hidden pockets throughout India in association with tuberculosis. India shows prevalence in HIV-associated Kaposi's sarcoma in regions where socially discriminated LGBT (lesbian, gay, bisexual, and transgender) groups, unprotected sexual behavior and heterosexuality are the important risk factors for sexually transmitted viral diseases. Anti-retro viral therapy is not sufficient to combat the virus and may act adversely. On a note regarding the clinical representations of Kaposi's sarcoma, oral, mucosal, pleural and abdominal involvements are observed in worst cases and these can be considered as the main manifesting criteria for this malignancy among Indians.

Citing Articles

Synthetic antioxidants from a natural source can overtake the oncogenic stress management system and activate the stress‑sensitized death of KSHV‑infected cancer cells.

Das P, Brahmachari G, Chatterjee K, Choudhuri T Int J Mol Med. 2022; 50(3).

PMID: 35856421 PMC: 9333903. DOI: 10.3892/ijmm.2022.5173.


Kaposi sarcoma (KS) with primary effusion lymphoma in HIV infected MSM (men having sex with men) co-infected with pulmonary tuberculosis and syphilis: a case report from India.

Bangar S, Vashisht R, Sonar P, Ghule K, Rawat L, Mane A AIDS Res Ther. 2022; 19(1):36.

PMID: 35842670 PMC: 9288045. DOI: 10.1186/s12981-022-00460-5.

References
1.
Kodra A, Walczyszyn M, Grossman C, Zapata D, Rambhatla T, Mina B . Case Report: Pulmonary Kaposi Sarcoma in a non-HIV patient. F1000Res. 2015; 4:1013. PMC: 4654435. DOI: 10.12688/f1000research.7137.1. View

2.
Joshi U, Ceena D, Ongole R, Sumanth K, Boaz K, Jeena Priy K . AIDS related Kaposi's sarcoma presenting with palatal and eyelid nodule. J Assoc Physicians India. 2013; 60:50-3. View

3.
Simonart T . Iron: a target for the management of Kaposi's sarcoma?. BMC Cancer. 2004; 4:1. PMC: 317471. DOI: 10.1186/1471-2407-4-1. View

4.
Jan R, Koul P, Ahmed M, Shah S, Mufti S, War F . Kaposi Sarcoma in a Non HIV Patient. Int J Health Sci (Qassim). 2011; 2(2):153-6. PMC: 3068733. View

5.
Dilnur P, Katano H, Wang Z, Osakabe Y, Kudo M, Sata T . Classic type of Kaposi's sarcoma and human herpesvirus 8 infection in Xinjiang, China. Pathol Int. 2002; 51(11):845-52. DOI: 10.1046/j.1440-1827.2001.01293.x. View